Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06787443 · ClinicalTrials.gov registry record · NA
Randomized Placebo Controlled Clinical Study of an Oral Product in Subjects With Menopausal Symptoms
A NA study, sponsored by Olly, PBC.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT06787443: Completed NA study, sponsored by Olly, PBC.
NCT06787443 is a NA study that has completed, run by Olly, PBC. The registered enrollment target is 88 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06787443, a NA study, has completed, sponsored by Olly, PBC.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
The objective of this study is to assess the safety and effectiveness of a dietary supplement for symptom relief in subjects with menopausal symptoms over the course of five weeks of continuous daily use.
Primary Outcome
To assess changes in symptom scores attained from product use in subjects with menopausal symptoms, including acute effects
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Dietary Supplement with Proprietary Herbal Extract Blend and GABA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2024-05-10 |
| Est. Completion | 2024-06-24 |
| Phase | NA |
What the finished NCT06787443 record still lists
NCT06787443 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06787443 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06787443 about?
NCT06787443 is a clinical study titled "Randomized Placebo Controlled Clinical Study of an Oral Product in Subjects With Menopausal Symptoms". The objective of this study is to assess the safety and effectiveness of a dietary supplement for symptom relief in subjects with menopausal symptoms over the course of five weeks of continuous daily use.
What is the current status of trial NCT06787443?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2024-05-10. Estimated completion is 2024-06-24.
What interventions are being tested in trial NCT06787443?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Dietary Supplement with Proprietary Herbal Extract Blend and GABA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06787443?
This trial is sponsored by Olly, PBC, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06787443's enrollment target sits among peer trials
88 972nd of 2000 higher than 1,027 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI